| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021225 |
| Receipt No. | R000024486 |
| Scientific Title | Effects of continous plasma filtration with dialysis therapy in severe septic patients with acute liver failure |
| Date of disclosure of the study information | 2016/02/27 |
| Last modified on | 2020/03/13 (Ver. 2) |
| Basic information | ||
| Public title | Effects of continous plasma filtration with dialysis therapy in severe septic patients with acute liver failure | |
| Acronym | Effects of CPDF in severe septic patients with acute liver failure | |
| Scientific Title | Effects of continous plasma filtration with dialysis therapy in severe septic patients with acute liver failure | |
| Scientific Title:Acronym | Effects of CPDF in severe septic patients with acute liver failure | |
| Region |
|
|
| Condition | ||||||
| Condition | severe sepsis with acute liver failure | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | We evaluated the effects of CPDF therapy in severe septic patients with acute liver failure. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Changes in the severity score (APACHE II and SOFA) at 5 days after CPDF therapy |
| Key secondary outcomes | Duration of ICU stay, duration of hospitality, survival rate at 28day after CPDF therapy, and changes in hemodynamics and respiratory function and biochemical data |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | CPDF therapy (+)
It is possible to treat CPDF therapy for 7 days. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with both the criteria of sepsis and the criteria of acute liver failure.
Sepsis is defined as SIRS with infection. Acute liver failure is defined as PT 40% or PT-INR >1,5 within 8 weeks. |
|||
| Key exclusion criteria | 1) During pregnancy or breast-feeding
2) The doctor has been deemed inappropriate 3) Not obtain consent from the patient or families |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kanazawa University Hospital | ||||||
| Division name | Intensive Care Unit | ||||||
| Zip code | |||||||
| Address | 13-1 Takara-machi, Kanazawa | ||||||
| TEL | 076-265-2430 | ||||||
| ttaniyan@med.kanazawa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kanazawa University Hospital | ||||||
| Division name | Intensive Care Unit | ||||||
| Zip code | |||||||
| Address | 13-1 Takara-machi, Kanazawa | ||||||
| TEL | 076-265-2430 | ||||||
| Homepage URL | |||||||
| ttaniyan@med.kanazawa-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kanazawa University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Intensive Care Unit, Kanazawa University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 金沢大学附属病院(石川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024486 |